Group aims to improve access to scientific programmes and grow ELRIG community
14 September, 2023
Taipei, Taiwan, 13th September 2023 / Sciad Newswire / BRIM Biotechnology, Inc. ("BRIM," TPEx 6885), a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint diseases, announced today that 22,500 shares have been issued at a premium of NT$65 (~US$2.03), raising a total of NT$1.4625 billion (~US$45.8 million). The rights issue was fully paid on 31st August 2023, four days early compared to the scheduled date of 4th September.
13 September, 2023
Sandwich, UK, 7th September 2023 / Sciad Newswire / Discovery Park, Kent’s thriving life science community, welcomes today’s announcement that the UK will re-join the EU’s Horizon science research programme.
12 September, 2023
Professional excellence, positive environmental impact, process safety and societal benefit are among the key qualities being celebrated by the Institution of Chemical Engineers (IChemE) as it announces the finalists for its 2023 Global Awards.
11 September, 2023